New bilingual telehealth platform · Launching 2026

The GLP-1 platform
MEDVi should have built.

Bilingual English/Spanish. All-inclusive transparent pricing. Real humans who answer the phone. Zero data breaches. Women's health from day one. Starting at $169/month.

Start your journey — $169/mo See how we compare
🔒 No data breaches — ever 🌎 English + Spanish 📞 Real humans, 2-hr response 👩 Women's health Day 1

¿Prefieres el español? REMEVi es la primera plataforma de salud GLP-1 completamente bilingüe de los EE.UU.

⚠️ Researching MEDVi? Read this first.

In January 2026, MEDVi's clinical partner OpenLoop Health suffered a 1.6 million patient data breach. MEDVi also received an FDA warning letter and is currently named in a federal class action lawsuit. REMEVi was built as the trustworthy, bilingual alternative — no breaches, no warnings, real care. See the full story →

$169
All-inclusive first month
0
Data breaches
2hr
Support response time
65M
US Hispanics underserved
2
Languages: English + Spanish
REMEVi vs MEDVi

How REMEVi stacks up against MEDVi

An honest, side-by-side comparison using publicly available data as of April 2026.

Feature REMEVi MEDVi
GLP-1 semaglutide (injectable) $169 intro / $279 ongoing — all-inclusive $179 intro / $299 ongoing
Hidden fees or separate billing None. All-inclusive pricing, always Reported billing surprises and double charges
Spanish language support Full bilingual English + Spanish — every touchpoint English only
Women's health Full program — GLP-1, HRT, hair, skin, mental health Partial — women's health listed as limited
Data security Zero breaches. HIPAA certified. 1.6M patient breach (OpenLoop, Jan 2026)
FDA status LegitScript certified. Full FDA compliance. FDA warning letter issued 2026
Legal / regulatory issues None Named in federal class action lawsuit (RICO)
Human phone support Yes — bilingual coordinators, 2-hour response Primarily automated. BBB complaints cite unresponsive support.
Cancellation policy One-click, instant, no penalty BBB complaints about cancellation difficulty
BBB rating A+ (target) F rating, 361 complaints
Before/after photos Real patients only. No AI-generated images. Deepfake before/after photos reported (Futurism)
Mobile app Bilingual app — progress, reminders, 1:1 video (Phase 2) Web portal only

*Comparison based on publicly available information, BBB records, FDA records, court filings, and customer reviews as of April 2026. MEDVi is a trademark of MEDVi LLC.

Why REMEVi

What MEDVi, Hims & Hers, and Ro
never built

Three platforms. Zero Spanish. Zero bilingual support. None of them built for the 65 million Americans who speak Spanish at home. We did.

🌎

Fully bilingual — not translated

Every intake form, every patient message, every support call — in English or Spanish from the first word. Not Google Translated. Built bilingual.

First in the US
💵

No hidden fees. Ever.

Hims charges $145/month before you get a single pill. Ro has a $45 bait-and-switch. REMEVi shows you the real all-inclusive price before you pay a cent.

What you see = what you pay
📞

Real humans. Not bots.

"You are NOT communicating with real medical providers" — that's an actual Hers customer review. REMEVi has bilingual care coordinators with a 2-hour response guarantee.

2-hour response SLA
👩‍⚕️

Women's health from Day 1

MEDVi has had "Women's Health — Coming Soon" for over a year. REMEVi launched with a full women's program: GLP-1, HRT, hair, skin, and mental health.

MEDVi's biggest gap
🔒

We have never been hacked.

In 2026, both MEDVi's partner and Hims & Hers confirmed major data breaches. REMEVi uses only HIPAA-certified infrastructure with a clean security record.

Zero breaches
✅

LegitScript certified

LegitScript certification means Google, Meta, and TikTok verify us as a legitimate healthcare platform. It's the same standard that MEDVi couldn't maintain.

Verified & compliant
Pricing

All-inclusive pricing.
No surprises.

Everything included — physician review, medication, shipping, and bilingual support. Compared to MEDVi and Ro, you pay less and get more.

GLP-1 Semaglutide
$169/mo
intro · then $279/mo ongoing
Everything included:
  • Licensed physician review
  • Compounded semaglutide
  • Free discreet shipping
  • Bilingual support
  • Patient portal access
  • No long-term contract
vs. MEDVi: $179 intro / $299 ongoing · vs. Ro: $474+ all-in
GLP-1 Tirzepatide
$289/mo
intro · then $369/mo ongoing
Everything included:
  • Licensed physician review
  • Compounded tirzepatide
  • Free discreet shipping
  • Bilingual support
  • Patient portal access
  • No long-term contract
vs. Hims: $1,899/mo for Mounjaro/Zepbound
Women's Health / HRT
$89/mo
intro · then $129/mo ongoing
Everything included:
  • Licensed physician review
  • HRT medication (if eligible)
  • Free discreet shipping
  • Bilingual women's care team
  • Patient portal access
  • No long-term contract
vs. MEDVi: women's health "Coming Soon" for 1+ year
Men's Health / TRT
$109/mo
intro · then $149/mo ongoing
Everything included:
  • Licensed physician review
  • Testosterone therapy (if eligible)
  • Free discreet shipping
  • Bilingual support
  • Patient portal access
  • No long-term contract
HSA/FSA eligible · No insurance required
Why patients are switching from MEDVi

What's happening at MEDVi in 2026

These are documented events from public records, federal filings, and verified news sources — not opinions.

FDA · February 2026

MEDVi receives FDA warning letter for misleading GLP-1 claims

The FDA issued a warning letter to MEDVi for claiming their compounded products contained "the same active ingredient" as FDA-approved drugs like Ozempic and Wegovy — a violation of federal advertising rules.

Source: FDA.gov, STAT News
Data Breach · January 2026

OpenLoop Health — MEDVi's clinical partner — confirms 1.6M patient breach

A threat actor breached OpenLoop Health's systems and exfiltrated records from approximately 1.6 million patients, including names, contact information, dates of birth, and medical information.

Source: Texas AG office notification, March 2026
Federal Lawsuit · November 2025

Class action RICO lawsuit filed against MEDVi and OpenLoop

A federal class action complaint alleges MEDVi was one of dozens of telehealth storefronts selling compounded oral tirzepatide with "no demonstrated mechanism of absorption or efficacy" — calling it "modern-day snake oil."

Source: US District Court for the District of Delaware
BBB · Current

MEDVi carries an F rating with 361 complaints on Better Business Bureau

Complaints center on cancellation difficulty, unexpected charges, unresponsive support, and billing after cancellation. The company has an F rating — the lowest possible BBB grade.

Source: Better Business Bureau public database

REMEVi was built specifically in response to these failures. We are not affiliated with MEDVi, OpenLoop Health, or any of their partners. We exist to be the alternative patients deserve.

Healthcare in your language.

Every GLP-1 telehealth platform in America — MEDVi, Hims, Ro — is English only. REMEVi is the first to serve the 65 million Spanish-speaking Americans who've been left out of the weight loss medication revolution.

Get started in English →

Salud en tu idioma.

REMEVi es la primera plataforma de salud GLP-1 completamente bilingüe en los EE.UU. Atención médica real, en español — desde la consulta hasta el seguimiento.

Empieza en español →
FAQ

Frequently asked questions

REMEVi was built to address MEDVi's documented failures: their FDA warning letter, their clinical partner's 1.6 million patient data breach, their F BBB rating, and their complete absence of Spanish-language support. REMEVi offers bilingual English/Spanish care, all-inclusive transparent pricing starting at $169/month, real human support with a 2-hour response guarantee, and full women's health services from launch day. Whether REMEVi is "better" depends on your needs — but if you're a Spanish speaker, a woman, or a patient who has experienced MEDVi's billing and support issues, the differences are significant.
In January 2026, OpenLoop Health — the clinical infrastructure company that powers MEDVi — confirmed a data breach. A threat actor gained access to their systems and exfiltrated records from approximately 1.6 million patients, including names, contact information, dates of birth, and medical information. MEDVi itself uses OpenLoop as its clinical partner, meaning MEDVi patient data was part of the breach. This was separately confirmed by the Texas Attorney General's office in March 2026. REMEVi does not use OpenLoop Health and has a clean data security record.
Yes — REMEVi is the first GLP-1 telehealth platform in the United States to offer fully bilingual English and Spanish service. This includes the patient intake questionnaire, all support communications, medication instructions, health education content, and patient portal. Our bilingual care coordinators are fluent in both languages. Sí — REMEVi es la primera plataforma de telesalud GLP-1 en los Estados Unidos con servicio completamente bilingüe en inglés y español.
REMEVi GLP-1 semaglutide starts at $169/month (intro) then $279/month — all-inclusive with physician review, medication, and free shipping. MEDVi starts at $179 then $299. Ro charges a $145/month membership fee before any medication, meaning their true all-in cost is $474–$544/month. Hims starts at $149 but also bills medication separately in many cases. REMEVi's pricing includes everything with no hidden fees or separate membership charges.
REMEVi offers compounded semaglutide (injectable and oral), compounded tirzepatide, and facilitates access to brand-name GLP-1 medications for eligible patients. All prescribing decisions are made by licensed physicians through our clinical partner. REMEVi also offers testosterone replacement therapy (TRT), hormone replacement therapy (HRT), hair and skin programs, and mental health support. We are a complete health platform — not just a GLP-1 company.
REMEVi is launching initially in Nevada, California, Texas, Florida, and New York — the states with the highest Hispanic populations and the greatest unmet need for bilingual healthcare. We will expand to all 50 states through our clinical partner's nationwide physician network. Sign up to be notified when REMEVi comes to your state.
Yes — one-click cancellation, instant, with no penalty or difficult phone calls required. This is a deliberate design choice. MEDVi's BBB complaints frequently cite cancellation difficulty and unexpected charges after cancellation. REMEVi advertises easy cancellation because we believe patients who can leave easily are patients who choose to stay.

Start your health journey today.

Bilingual telehealth. Transparent pricing. Real care. Starting at $169/month all-inclusive.

Start in English → Empezar en Español →

No insurance needed · Cancel anytime · LegitScript certified · HIPAA compliant

Available in NV, CA, TX, FL, NY — more states coming soon